SciBase Holding AB (publ) (SCIB.ST)
SciBase Holding AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sundbyberg, AB, SE. The stock last traded at $15.40, down 1.28% on the session, giving a market capitalisation of $157.5M. Its beta of 0.04 implies it has historically moved less than the broad market.
SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key offerings, Nevisense and Nevisense Go, comprise a point-of-care platform designed for the detection of melanoma and non-melanoma skin cancers, as well as for evaluating skin barrier function. The company also maintains a collaborative agreement with the Advanced Dermatology and Cosmetic Surgery (ADCS) group.
SciBase Holding AB (publ) is most often compared with the following Healthcare names: